Signals, Powered By EquityPandit
Jubilant Life Science has got the US health regulator’s final approval for its generic version of anti-depressant Paxil tablets.
The company said in a BSE filing that the “final approval for the abbreviated new drug application (ANDA) from the US Food and Drug Administration (USFDA) for Paroxetine tablets of Apotex is for strengths of 10 mg, 20 mg, 30 mg and 40 mg.
